Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02929849 · ClinicalTrials.gov registry record · NA
Satiety and Glucose Indices in Adults
A NA study, sponsored by Rutgers University.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT02929849 is a NA study that has completed, run by Rutgers University. The registered enrollment target is 51 participants.
The verdict
NCT02929849, a NA study, has completed, sponsored by Rutgers University.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether an herb with known alpha-glucosidase inhibitor properties (Salacia Chinensis, SC), affects postprandial appetite ratings and glucose indices in overweight/obese individuals.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT 300 mg SC
- DIETARY_SUPPLEMENT 500 mg SC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02929849
The ClinicalTrials.gov registry entry for NCT02929849 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers University, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02929849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02929849 about?
NCT02929849 is a clinical study titled "Satiety and Glucose Indices in Adults". The purpose of this study is to determine whether an herb with known alpha-glucosidase inhibitor properties (Salacia Chinensis, SC), affects postprandial appetite ratings and glucose indices in overweight/obese individuals.
What is the current status of trial NCT02929849?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2015-08. Estimated completion is 2017-01-01.
What interventions are being tested in trial NCT02929849?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 300 mg SC (DIETARY_SUPPLEMENT), 500 mg SC (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02929849?
This trial is sponsored by Rutgers University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.